![Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension](https://www.ahajournals.org/cms/asset/89dcd157-b34a-40c1-b8f1-fd1ddd994952/hypertensionaha.121.18503.fig07.jpg)
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
![Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/cn200128x/asset/images/medium/cn-2011-00128x_0006.gif)
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
![Proteomes | Free Full-Text | Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA Proteomes | Free Full-Text | Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA](https://pub.mdpi-res.com/proteomes/proteomes-06-00039/article_deploy/html/images/proteomes-06-00039-g001.png?1570548185)
Proteomes | Free Full-Text | Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA
![Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00680/article_deploy/html/images/pharmaceuticals-15-00680-ag-550.jpg)
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
![Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b01924/asset/images/large/jm9b01924_0027.jpeg)
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry
![6,5‐Fused Ring, C2‐Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects** - Akins - 2022 - ChemMedChem - Wiley Online Library 6,5‐Fused Ring, C2‐Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects** - Akins - 2022 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/4de101d7-7814-4dea-9495-46f4cd5dbc0c/cmdc202100684-toc-0001-m.png)
6,5‐Fused Ring, C2‐Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects** - Akins - 2022 - ChemMedChem - Wiley Online Library
![Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors](https://www.mdpi.com/molecules/molecules-27-00919/article_deploy/html/images/molecules-27-00919-ag.png)
Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
![Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be0dab9f-5eed-4be6-942d-998c462787b6/tra12582-toc-0001-m.jpg?trick=1666529551600)
Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library
![Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion | Neuropsychopharmacology Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2013.76/MediaObjects/41386_2013_Article_BFnpp201376_Fig1_HTML.jpg)
Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion | Neuropsychopharmacology
![Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling](https://pubs.acs.org/cms/10.1021/acs.jcim.0c00890/asset/images/large/ci0c00890_0010.jpeg)
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
![Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula - ScienceDirect Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352289520300576-fx1.jpg)
Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula - ScienceDirect
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
![Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00892/article_deploy/html/images/pharmaceuticals-15-00892-g002.png)
Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects
![Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ... Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00503/asset/images/medium/jm0c00503_0001.gif)
Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...
![Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-019-0423-7/MediaObjects/41386_2019_423_Fig1_HTML.png)
Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology
![Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens | Neuropsychopharmacology Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2014.157/MediaObjects/41386_2014_Article_BFnpp2014157_Fig1_HTML.jpg)